FerreiraFLBotaDPBrossA. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA2001;286: 1754–58.
2.
ChristianMDHawryluckLWaxRS. Development of a triage protocol for critical care during an influenza pandemic. CMAJ2006;175: 1377–81.
3.
McDermidRCStelfoxHTBagshawSM. Frailty in the critically ill: a novel concept. Crit Care2001;15: 301.
4.
BultersDBelliA. A prospective study of the time to evacuate acute subdural and extradural haematomas. Anaesthesia2009;64: 277–81.
5.
HotchkissRSSwansonPEFreemanBD. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med1999;27: 1230–51.
6.
NobleJSMacKirdyFNDonaldsonSIHowieJC. Renal and respiratory failure in Scottish ICUs?Anaesthesia2001; 56: 124–29.
7.
SingerMDe SantisVVitaleDJeffcoateW. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet2004;364: 545–48.
8.
WeinbergED. Iron withholding: a defense against infection and neoplasia. Physiol Rev1984;64: 65–102.
9.
WeinbergED. Iron availability and infection?Biochim Biophys Acta2009; 1790: 600–05.
10.
GabayCKushnerI. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med1999;340: 448–54.
11.
Vander HeidenMGCantleyLCThompsonCB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science2009;324: 1029–33.
12.
WilliamsGCNesseRM. The Dawn of Darwinian Medicine. Q Rev Biol1991;66: 1–22.
13.
HébertPCWellsMTweeddaleC. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med1997;155: 1618–23.
14.
ZarychanskiRHoustonDS. Anaemia of chronic disease: a harmful disorder or an adaptive, beneficial response?CMAJ2008;179: 333–37.
15.
SchaibleUEKaufmannSHE. Iron and microbial infection. Nat Rev Microbiol2004;2: 946–53.
16.
LieuPTHeiskalaMPetersonPAYangY. The roles of iron in health and disease. Mol Aspects Med2001;22: 1–87.
17.
KlugerMJRothenburgBA. Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science1979;203: 374–76.
18.
LeGrandEKAlcockJ. Turning up the heat: immune brinksmanship in the acute-phase response. Q Rev Biol2012;87: 3–18.
19.
KlugerMJRinglerDHAnverMR. Fever and survival. Science1975;188: 166–68.
20.
WilliamsGCNesseRM. Evolution and Healing: The New Science of Darwinian Medicine, 1st Edition, New York: Times Books, 1995.
21.
FishmanNO. Antimicrobial management and cost containment. In: MandellGEBennetJEDolinR, eds. Principles and Practice of Infectious Diseases.5th ed.London: Churchill Livingstone; 2000. 539–46.
22.
GrunebergRNWilsonAP. Anti-infective treatment in intensive care: the role of glycopeptides. Intensive Care Med1994;20: S17–S22.
23.
BergmansDCBontenMJGaillardCA. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother1997;39: 527–35.
24.
WatsonNADentonM. Antibiotic prescribing in critical care: general principles. JICS2007;8: 17–19.
25.
GeisslerAGerbeauxPGranierI. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med2003;29: 49–54.
26.
GaieskiDFMikkelsenMEBandRA. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med2010;38: 1045–53.
27.
BouadmaLLuytCETubachF. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet2010;375: 463–47.
28.
MicekSTWelchECKhanJ. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with gram-negative bacteremia. J Hosp Med2011;6: 405–10.
29.
RossoliniGMThallerMC. Coping with antibiotic resistance: contributions from genomics. Genome Med2012;2: 15.
30.
LouieRFTangZAlbertsonTE. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med2008;36: 1487–92.
31.
HanceKHowsonDLindseyM. Rapid identification of live Acinetobacter spp. in bronchoalveolar lavage specimens by automated immunofluorescence microscopy [abstract]. As presented at the 47th ICAAC, Chicago, IL, 2007, September, Poster K-392.
BergeronMGKeDMénardC. Rapid detection of group B Streptococci in pregnant women at delivery. NEJM2000;343: 17–79.
34.
PaulMNielsenAD, Goldberg E for the TREAT Study Group. Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system. J Antimicrob Chemother2007;59: 1204–07.
35.
McGregorJCWeekesEForrestGN. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc2006;13: 378–84.
36.
ChastreJWolffMFagonJY. Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA2003;290: 2588–98.
37.
KollefMH. Optimising antibiotic therapy in the intensive care unit setting. Crit Care2001;5: 189–95.